Friedlander ML - Search Results

1

REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer.

Sjoquist KM, Espinoza D, Mileshkin L, Ananda S, Shannon C, Yip S, Goh J, Bowtell D, Harrison M, Friedlander ML. Sjoquist KM, et al. Among authors: friedlander ml. Gynecol Oncol. 2021 May;161(2):374-381. doi: 10.1016/j.ygyno.2021.02.002. Epub 2021 Feb 23. Gynecol Oncol. 2021. PMID: 33637349 Free article. Clinical Trial.

2

Dual sequential non-cross-resistant chemotherapy for advanced stage squamous cell carcinoma of the cervix.

Levi JA, Wheeler HR, Friedlander M, Tattersall MH, Kefford R, Dalley D. Levi JA, et al. Gynecol Oncol. 1992 Jun;45(3):329-33. doi: 10.1016/0090-8258(92)90314-9. Gynecol Oncol. 1992. PMID: 1377155

3

Hypercalcemia in association with mucinous adenocarcinoma of the ovary: a case report.

Boyer M, Friedlander M, Bannatyne P, Atkinson K. Boyer M, et al. Gynecol Oncol. 1989 Dec;35(3):387-90. doi: 10.1016/0090-8258(89)90085-1. Gynecol Oncol. 1989. PMID: 2557271

4

A phase II study of carboplatin and cisplatin in advanced ovarian cancer.

Segelov E, Stuart-Harris R, Bell D, Tattersall M, Hutton-Potts J, Friedlander M. Segelov E, et al. Eur J Gynaecol Oncol. 1994;15(4):277-82. Eur J Gynaecol Oncol. 1994. PMID: 7957335 Clinical Trial.

5

Australasian multicentre phase II study of paclitaxel (Taxol) in relapsed ovarian cancer.

Phillips KA, Friedlander M, Olver I, Evans B, Smith J, Fitzharris B, McCrystal M, Joughin J, Bishop J. Phillips KA, et al. Aust N Z J Med. 1995 Aug;25(4):337-43. doi: 10.1111/j.1445-5994.1995.tb01899.x. Aust N Z J Med. 1995. PMID: 8540875 Clinical Trial.

6

A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer.

Friedlander M, Millward MJ, Bell D, Bugat R, Harnett P, Moreno JA, Campbell L, Varette C, Ripoche V, Kayitalire L. Friedlander M, et al. Ann Oncol. 1998 Dec;9(12):1343-5. doi: 10.1023/a:1008469212268. Ann Oncol. 1998. PMID: 9932166 Free article. Clinical Trial.

7

Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.

Meiser B, Butow P, Barratt A, Friedlander M, Gattas M, Kirk J, Suthers G, Walpole I, Tucker K. Meiser B, et al. Gynecol Oncol. 1999 Oct;75(1):122-9. doi: 10.1006/gyno.1999.5544. Gynecol Oncol. 1999. PMID: 10502438

8

Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study.

Tiller K, Meiser B, Butow P, Clifton M, Thewes B, Friedlander M, Tucker K. Tiller K, et al. Gynecol Oncol. 2002 Aug;86(2):212-9. doi: 10.1006/gyno.2002.6737. Gynecol Oncol. 2002. PMID: 12144830

9

Carboplatin hypersensitivity reactions: re-treatment with cisplatin desensitisation.

Jones R, Ryan M, Friedlander M. Jones R, et al. Gynecol Oncol. 2003 Apr;89(1):112-5. doi: 10.1016/s0090-8258(03)00066-0. Gynecol Oncol. 2003. PMID: 12694663 Clinical Trial.

10

A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer.

Rischin D, Phillips KA, Friedlander M, Harnett P, Quinn M, Richardson G, Martin A. Rischin D, et al. Gynecol Oncol. 2004 May;93(2):417-21. doi: 10.1016/j.ygyno.2004.01.037. Gynecol Oncol. 2004. PMID: 15099955 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters